BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 23171920)

  • 1. Understanding lentiviral vector chromatin targeting: working to reduce insertional mutagenic potential for gene therapy.
    Papayannakos C; Daniel R
    Gene Ther; 2013 Jun; 20(6):581-8. PubMed ID: 23171920
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Host factors for retroviral integration site selection.
    Debyser Z; Christ F; De Rijck J; Gijsbers R
    Trends Biochem Sci; 2015 Feb; 40(2):108-16. PubMed ID: 25555456
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Towards a Safer, More Randomized Lentiviral Vector Integration Profile Exploring Artificial LEDGF Chimeras.
    Vranckx LS; Demeulemeester J; Debyser Z; Gijsbers R
    PLoS One; 2016; 11(10):e0164167. PubMed ID: 27788138
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transient and stable knockdown of the integrase cofactor LEDGF/p75 reveals its role in the replication cycle of human immunodeficiency virus.
    Vandekerckhove L; Christ F; Van Maele B; De Rijck J; Gijsbers R; Van den Haute C; Witvrouw M; Debyser Z
    J Virol; 2006 Feb; 80(4):1886-96. PubMed ID: 16439544
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monitoring for potential adverse effects of prenatal gene therapy: genotoxicity analysis in vitro and on small animal models ex vivo and in vivo.
    Themis M
    Methods Mol Biol; 2012; 891():341-70. PubMed ID: 22648780
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gene therapy progress and prospects: development of improved lentiviral and retroviral vectors--design, biosafety, and production.
    Sinn PL; Sauter SL; McCray PB
    Gene Ther; 2005 Jul; 12(14):1089-98. PubMed ID: 16003340
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A critical role for alternative polyadenylation factor CPSF6 in targeting HIV-1 integration to transcriptionally active chromatin.
    Sowd GA; Serrao E; Wang H; Wang W; Fadel HJ; Poeschla EM; Engelman AN
    Proc Natl Acad Sci U S A; 2016 Feb; 113(8):E1054-63. PubMed ID: 26858452
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Integration site selection by retroviruses.
    Cereseto A; Giacca M
    AIDS Rev; 2004; 6(1):13-21. PubMed ID: 15168737
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An essential role for LEDGF/p75 in HIV integration.
    Llano M; Saenz DT; Meehan A; Wongthida P; Peretz M; Walker WH; Teo W; Poeschla EM
    Science; 2006 Oct; 314(5798):461-4. PubMed ID: 16959972
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Integrase-defective lentiviral vectors: progress and applications.
    Banasik MB; McCray PB
    Gene Ther; 2010 Feb; 17(2):150-7. PubMed ID: 19847206
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Progress in improvement of lentiviral vectors' transcriptional read-through].
    He J; Zhang J
    Sheng Wu Gong Cheng Xue Bao; 2011 Nov; 27(11):1541-8. PubMed ID: 22393708
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of the PWWP domain of lens epithelium-derived growth factor (LEDGF)/p75 cofactor in lentiviral integration targeting.
    Gijsbers R; Vets S; De Rijck J; Ocwieja KE; Ronen K; Malani N; Bushman FD; Debyser Z
    J Biol Chem; 2011 Dec; 286(48):41812-41826. PubMed ID: 21987578
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Approaches towards directed DNA integration by the use of retroviral integrases and transposases].
    Kniazhanskaia ES; Kondrashina OV; Gottikh MB
    Mol Biol (Mosk); 2011; 45(6):931-48. PubMed ID: 22295563
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of gene-trapping efficiency between retroviral and lentiviral vectors in mouse embryonic stem cells.
    Yamaguchi T; Morikawa A; Miyoshi H
    Biochem Biophys Res Commun; 2012 Aug; 425(2):297-303. PubMed ID: 22842569
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Virus evolution reveals an exclusive role for LEDGF/p75 in chromosomal tethering of HIV.
    Hombrouck A; De Rijck J; Hendrix J; Vandekerckhove L; Voet A; De Maeyer M; Witvrouw M; Engelborghs Y; Christ F; Gijsbers R; Debyser Z
    PLoS Pathog; 2007 Mar; 3(3):e47. PubMed ID: 17397262
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diverse genomic integration of a lentiviral vector developed for the treatment of Wiskott-Aldrich syndrome.
    Mantovani J; Charrier S; Eckenberg R; Saurin W; Danos O; Perea J; Galy A
    J Gene Med; 2009 Aug; 11(8):645-54. PubMed ID: 19455589
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Retroviral DNA integration: HIV and the role of LEDGF/p75.
    Ciuffi A; Bushman FD
    Trends Genet; 2006 Jul; 22(7):388-95. PubMed ID: 16730094
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lentiviruses in gene therapy clinical research.
    Connolly JB
    Gene Ther; 2002 Dec; 9(24):1730-4. PubMed ID: 12457288
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insertion of retroviral vectors in NOD/SCID repopulating human peripheral blood progenitor cells occurs preferentially in the vicinity of transcription start regions and in introns.
    Laufs S; Nagy KZ; Giordano FA; Hotz-Wagenblatt A; Zeller WJ; Fruehauf S
    Mol Ther; 2004 Nov; 10(5):874-81. PubMed ID: 15509505
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The LAM-PCR Method to Sequence LV Integration Sites.
    Wang W; Bartholomae CC; Gabriel R; Deichmann A; Schmidt M
    Methods Mol Biol; 2016; 1448():107-20. PubMed ID: 27317177
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.